2013 Q4 Form 10-Q Financial Statement

#000156066413000130 Filed on November 15, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $30.00K $26.20K $45.06K
YoY Change -50.0% -41.86% -87.75%
Cost Of Revenue $20.00K $22.75K $23.90K
YoY Change -33.33% -4.8% -93.11%
Gross Profit $10.00K $3.447K $21.16K
YoY Change -50.0% -83.71% -0.51%
Gross Profit Margin 33.33% 13.16% 46.97%
Selling, General & Admin $250.0K $230.0K $290.0K
YoY Change 92.31% -20.69% -23.68%
% of Gross Profit 2500.0% 6672.47% 1370.25%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.00K $20.00K $20.00K
YoY Change -50.0% 0.0% -60.0%
% of Gross Profit 100.0% 580.21% 94.5%
Operating Expenses $250.0K $231.4K $289.6K
YoY Change 78.57% -20.12% -25.01%
Operating Profit -$240.0K -$227.9K -$268.5K
YoY Change 100.0% -15.11% -26.43%
Interest Expense -$90.00K $8.355K $0.00
YoY Change 800.0% -100.0%
% of Operating Profit
Other Income/Expense, Net -$368.5K -$2.250K
YoY Change 16278.84% -141.55%
Pretax Income -$380.0K -$600.0K -$270.0K
YoY Change 72.73% 122.22% -25.0%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$380.0K -$596.5K -$270.7K
YoY Change 72.73% 120.31% -24.7%
Net Earnings / Revenue -1266.67% -2276.7% -600.8%
Basic Earnings Per Share
Diluted Earnings Per Share -$222.2K -$422.5K -$254.7K
COMMON SHARES
Basic Shares Outstanding 129.3M shares 106.7M shares 79.31M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $60.00K $60.00K $10.00K
YoY Change 100.0% 500.0% -50.0%
Cash & Equivalents $64.75K $57.50K $14.69K
Short-Term Investments
Other Short-Term Assets $27.74K $84.11K $14.96K
YoY Change 241.92% 462.44% -48.92%
Inventory $766.00 $2.246K $1.955K
Prepaid Expenses
Receivables $0.00 $0.00 $20.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $95.15K $146.6K $54.75K
YoY Change 105.12% 167.72% -82.79%
LONG-TERM ASSETS
Property, Plant & Equipment $7.722K $50.54K $132.0K
YoY Change -92.89% -61.71% -50.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $25.97K
YoY Change 136.71%
Total Long-Term Assets $89.94K $126.5K $158.0K
YoY Change -33.18% -19.91% -43.21%
TOTAL ASSETS
Total Short-Term Assets $95.15K $146.6K $54.75K
Total Long-Term Assets $89.94K $126.5K $158.0K
Total Assets $185.1K $273.1K $212.7K
YoY Change 2.27% 28.38% -64.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $310.0K $370.0K $360.0K
YoY Change -20.51% 2.78% 176.92%
Deferred Revenue
YoY Change
Short-Term Debt $90.00K $20.00K $30.00K
YoY Change 200.0% -33.33%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $830.8K $761.1K $630.4K
YoY Change 17.0% 20.74% 62.89%
LONG-TERM LIABILITIES
Long-Term Debt $240.0K $280.0K $0.00
YoY Change
Other Long-Term Liabilities $410.0K $320.0K
YoY Change
Total Long-Term Liabilities $650.0K $600.0K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $830.8K $761.1K $630.4K
Total Long-Term Liabilities $650.0K $600.0K $0.00
Total Liabilities $1.480M $1.358M $630.4K
YoY Change 108.44% 115.46% 62.89%
SHAREHOLDERS EQUITY
Retained Earnings -$15.44M -$15.06M -$13.71M
YoY Change 10.8% 9.79% 10.49%
Common Stock $131.4K $120.5K $81.66K
YoY Change 53.81% 47.58% -99.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.295M -$1.085M -$417.7K
YoY Change
Total Liabilities & Shareholders Equity $185.1K $273.1K $212.7K
YoY Change 2.27% 28.38% -64.33%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$380.0K -$596.5K -$270.7K
YoY Change 72.73% 120.31% -24.7%
Depreciation, Depletion And Amortization $10.00K $20.00K $20.00K
YoY Change -50.0% 0.0% -60.0%
Cash From Operating Activities -$140.0K -$100.0K $0.00
YoY Change 1300.0% -100.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 140.0K 130.0K 10.00K
YoY Change 366.67% 1200.0%
NET CHANGE
Cash From Operating Activities -140.0K -100.0K 0.000
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 140.0K 130.0K 10.00K
Net Change In Cash 0.000 30.00K 10.00K
YoY Change -100.0% 200.0% -103.23%
FREE CASH FLOW
Cash From Operating Activities -$140.0K -$100.0K $0.00
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$140.0K -$100.0K $0.00
YoY Change 1300.0% -100.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
GTX Corp
dei Entity Central Index Key
EntityCentralIndexKey
0001375793
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
129349252 shares
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30649 usd
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57497 usd
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91639 usd
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14686 usd
CY2012Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
6069 usd
CY2013Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
2718 usd
CY2012Q4 us-gaap Inventory Net
InventoryNet
1557 usd
CY2013Q3 us-gaap Inventory Net
InventoryNet
2246 usd
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
8113 usd
CY2013Q3 us-gaap Other Assets Current
OtherAssetsCurrent
84113 usd
CY2012Q4 us-gaap Assets Current
AssetsCurrent
46388 usd
CY2013Q3 us-gaap Assets Current
AssetsCurrent
146574 usd
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
108635 usd
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
120511 usd
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13316439 usd
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13849639 usd
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13930955 usd
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15055329 usd
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-529115 usd
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
-1085179 usd
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
180995 usd
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50538 usd
CY2012Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
25972 usd
CY2013Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
75972 usd
CY2012Q4 us-gaap Assets
Assets
180995 usd
CY2013Q3 us-gaap Assets
Assets
273084 usd
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
231633 usd
CY2013Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
318028 usd
CY2012Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
392834 usd
CY2013Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
367958 usd
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
28722 usd
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
21057 usd
CY2012Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
23000 usd
CY2013Q3 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
0 usd
CY2012Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 usd
CY2013Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
15000 usd
CY2012Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3541 usd
CY2013Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
7437 usd
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
710110 usd
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
761135 usd
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
85401 usd
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
273084 usd
CY2012Q4 us-gaap Liabilities
Liabilities
710110 usd
CY2013Q3 us-gaap Liabilities
Liabilities
1358263 usd
CY2012Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
30380 usd
CY2013Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
31655 usd
CY2012Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2013Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
277735 usd
CY2012Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0 usd
CY2013Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
319393 usd
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33132 usd
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41222 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
253420 usd
us-gaap Operating Expenses
OperatingExpenses
730344 usd
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2071000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2071000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85401372 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
120510827 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85401372 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
120510827 shares
us-gaap Revenues
Revenues
121610 usd
CY2013Q3 us-gaap Revenues
Revenues
26198 usd
CY2012Q3 us-gaap Revenues
Revenues
45062 usd
us-gaap Revenues
Revenues
309922 usd
us-gaap Cost Of Goods Sold
CostOfGoodsSold
69283 usd
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
22751 usd
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
23898 usd
us-gaap Cost Of Goods Sold
CostOfGoodsSold
256974 usd
us-gaap Gross Profit
GrossProfit
52327 usd
CY2013Q3 us-gaap Gross Profit
GrossProfit
3447 usd
CY2012Q3 us-gaap Gross Profit
GrossProfit
21164 usd
us-gaap Gross Profit
GrossProfit
52948 usd
GTXO Wages And Professional Fees
WagesAndProfessionalFees
603831 usd
CY2013Q3 GTXO Wages And Professional Fees
WagesAndProfessionalFees
198241 usd
CY2012Q3 GTXO Wages And Professional Fees
WagesAndProfessionalFees
248424 usd
GTXO Wages And Professional Fees
WagesAndProfessionalFees
808174 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
126513 usd
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
231373 usd
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
289646 usd
us-gaap Operating Expenses
OperatingExpenses
1061594 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-678017 usd
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-227926 usd
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-268482 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1008646 usd
GTXO Finance Costs
FinanceCosts
200000 usd
CY2013Q3 GTXO Finance Costs
FinanceCosts
200000 usd
CY2012Q3 GTXO Finance Costs
FinanceCosts
2250 usd
GTXO Finance Costs
FinanceCosts
6500 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-104868 usd
CY2013Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-52106 usd
CY2012Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-124378 usd
CY2013Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-108063 usd
CY2012Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
us-gaap Interest Expense
InterestExpense
17112 usd
CY2013Q3 us-gaap Interest Expense
InterestExpense
8355 usd
CY2012Q3 us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
CY2013Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
CY2012Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
16250 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-446358 usd
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-368524 usd
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2250 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9750 usd
us-gaap Net Income Loss
NetIncomeLoss
-1124375 usd
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-596450 usd
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-270732 usd
us-gaap Net Income Loss
NetIncomeLoss
-998896 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
97705298 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106711903 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79312901 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57396718 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Depreciation
Depreciation
58097 usd
us-gaap Depreciation
Depreciation
78785 usd
us-gaap Share Based Compensation
ShareBasedCompensation
84303 usd
us-gaap Share Based Compensation
ShareBasedCompensation
277816 usd
us-gaap Impaired Assets To Be Disposed Of By Method Other Than Sale Amount Of Impairment Loss
ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss
0 usd
us-gaap Impaired Assets To Be Disposed Of By Method Other Than Sale Amount Of Impairment Loss
ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss
103000 usd
GTXO Line Payable Finance Costs
LinePayableFinanceCosts
200000 usd
GTXO Line Payable Finance Costs
LinePayableFinanceCosts
4500 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3351 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
106683 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-689 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
142995 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
105000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-7927 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
100706 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-26158 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
143374 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
236150 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-7665 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-140737 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-208652 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-240039 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14549 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14549 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
270000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
25625 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
34500 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
152010 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
235500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
177635 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
26848 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-76953 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
131558 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
171450 usd
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
16000 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
145000 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
36000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-80399 usd
CY2013Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-14534 usd
CY2012Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 usd
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Basis of Presentation</u></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited consolidated financial statements of GTX have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and applicable regulations of the U.S. Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been omitted pursuant to such rules and regulations. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of financial position and results of operations have been included. Our operating results for the nine months ended September 30, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. The accompanying unaudited consolidated financial statements should be read in conjunction with our audited consolidated financial statements for the year ended December 31, 2012, which are included in our Annual Report on Form 10-K.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements reflect the accounts of GTX Corp and its wholly owned subsidiaries. All significant inter-company balances and transactions have been eliminated.</p>
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Accounting Estimates</u></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the accompanying unaudited consolidated financial statements requires the use of estimates that affect the reported amounts of assets, liabilities, revenues, expenses and contingencies.&#160; These estimates include, but are not limited to, estimates related to revenue recognition, allowance for doubtful accounts, inventory valuation, tangible and intangible long-term asset valuation, warranty and other obligations and commitments.&#160; Estimates are updated on an ongoing basis and are evaluated based on historical experience and current circumstances.&#160; Changes in facts and circumstances in the future may give rise to changes in these estimates which may cause actual results to differ from current estimates.</p>
us-gaap Reclassifications
Reclassifications
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Reclassifications</u></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For comparability, certain prior period amounts have been reclassified, where appropriate, to conform to the financial statement presentation used in 2013. These reclassifications have no impact on net loss.</p>
CY2013Q3 GTXO Working Capital
WorkingCapital
-615000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-1139140 shares
CY2012Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
23000 usd
CY2012Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0 usd
CY2013Q3 GTXO Amount Of Tranche
AmountOfTranche
425000 usd
CY2013Q3 GTXO Tranche Obligation
TrancheObligation
901000 usd
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
8000100 shares
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
204777 usd
CY2013Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
122597 usd
CY2012Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
GTXO Shares Issued For Services Rendered Value
SharesIssuedForServicesRenderedValue
68300 usd
GTXO Shares Issued For Services Rendered Shares
SharesIssuedForServicesRenderedShares
3800000 shares
GTXO Shares Issued For Accrued Expenses Value
SharesIssuedForAccruedExpensesValue
186450 usd
CY2013Q4 GTXO Shares Issued For Accrued Expenses Value
SharesIssuedForAccruedExpensesValue
50000 usd
GTXO Shares Issued For Accrued Expenses Shares
SharesIssuedForAccruedExpensesShares
14350000 shares
CY2013Q4 GTXO Shares Issued For Accrued Expenses Shares
SharesIssuedForAccruedExpensesShares
4166667 shares
GTXO Shares Issued With Repurchase Rights Value
SharesIssuedWithRepurchaseRightsValue
9315 usd
GTXO Shares Issued With Repurchase Rights Shares
SharesIssuedWithRepurchaseRightsShares
1000000 shares
GTXO Stock Issued During Period Value Conversion Of Convertible Debt
StockIssuedDuringPeriodValueConversionOfConvertibleDebt
82371 usd
GTXO Shares Issued For Financing Value
SharesIssuedForFinancingValue
49187 usd
GTXO Shares Issued For Financing Shares
SharesIssuedForFinancingShares
2459355 shares
GTXO Issuance Of Common Stock For Advisory Agreement
IssuanceOfCommonStockForAdvisoryAgreement
145000 usd
GTXO Issuance Of Common Stock For Advisory Agreement Shares
IssuanceOfCommonStockForAdvisoryAgreementShares
5500000 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
540623 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
35109455 shares
CY2013Q3 GTXO Warrants Outstanding At.08 Exercise Price
WarrantsOutstandingAt.08ExercisePrice
5720000 shares
CY2013Q3 GTXO Warrants Outstanding At.02 Exercise Price
WarrantsOutstandingAt.02ExercisePrice
2000000 shares
CY2013Q3 GTXO Total Warrants Outstanding
TotalWarrantsOutstanding
7720000 shares
CY2013Q3 GTXO Remaining Life Of Warrants At.08 Exercise Price
RemainingLifeOfWarrantsAt.08ExercisePrice
P4M20D
CY2013Q3 GTXO Remaining Life Of Warrants.02 Exercise Price In Years
RemainingLifeOfWarrants.02ExercisePriceInYears
P1Y11M8D
CY2013Q3 GTXO Total Remaining Life Warrants Years
TotalRemainingLifeWarrantsYears
P9M14D
CY2013Q3 GTXO Warrants Exercisable At.08 Exercise Price
WarrantsExercisableAt.08ExercisePrice
5720000 shares
CY2013Q3 GTXO Warrants Exerciseable02 Exercise Price
WarrantsExerciseable02ExercisePrice
2000000 shares
CY2013Q3 GTXO Warrants Exercisable Total
WarrantsExercisableTotal
7720000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2328570 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1189430 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1189430 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.20
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.167
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.22
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.167
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P3M18D
CY2012 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P1Y0M7D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3M18D
CY2013Q2 GTXO Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingGrantDateFairValue
131679 usd
CY2012Q4 GTXO Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingGrantDateFairValue
205234 usd
CY2013Q3 GTXO Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingGrantDateFairValue
90017 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
GTXO Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageGrantDateFairValue
-115217 usd
GTXO Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageGrantDateFairValue
-73555 usd
CY2013Q2 GTXO Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue
131679 usd
CY2013Q3 GTXO Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue
90017 usd
CY2013Q2 GTXO Compensation Advisory Agreement Shares
CompensationAdvisoryAgreementShares
3000000 shares
CY2013Q2 GTXO Compensation Advisory Agreement Shares
CompensationAdvisoryAgreementShares
2500000 shares
CY2013Q2 GTXO Compensation Advisory Agreement Value
CompensationAdvisoryAgreementValue
120000 usd
CY2013Q2 GTXO Compensation Advisory Agreement Value
CompensationAdvisoryAgreementValue
25000 usd
CY2013Q1 GTXO Term Of Advisory Agreement
TermOfAdvisoryAgreement
P1Y
CY2013Q2 GTXO Term Of Advisory Agreement
TermOfAdvisoryAgreement
P1Y
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
7000000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1482000 shares
us-gaap Temporary Equity Contract Terms
TemporaryEquityContractTerms
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">on July 12, 2013 (See Note 4), the Company issued a Warrant to Atlantic, whereby Atlantic is entitled to purchase from the Company a total number of shares of common stock, such that, when added to the total number of shares of common stock acquired by Atlantic upon conversion of the Atlantic Note, equals 12% of the common stock outstanding as of the date of such conversion, as such total outstanding amount may, be increased by issuances of common stock occurring on or prior to November 13, 2014 (or by issuances of common stock occurring after November 13, 2014 but pursuant to convertible instruments issued or commitments made by the Company prior to November 13, 2014), other than issuances of excluded securities as such term is defined in the Atlantic Note, at an exercise price per share equal to $0.001 per share, at any time and from time to time on or after the Closing Date and through and including November 13, 2020. As of the date of this Quarterly Report, Atlantic has not converted any portion of the Atlantic Note.</p>
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5310 usd
CY2013Q4 GTXO Price Per Share Issued For Accrued Expenses
PricePerShareIssuedForAccruedExpenses
0.012
CY2012Q4 us-gaap Debt Current
DebtCurrent
26541 usd
CY2013Q3 us-gaap Debt Current
DebtCurrent
22437 usd
GTXO Issuance Of Convertible Debt For Insoles
IssuanceOfConvertibleDebtForInsoles
50000 usd
GTXO Issuance Of Convertible Debt For Insoles
IssuanceOfConvertibleDebtForInsoles
0 usd

Files In Submission

Name View Source Status
0001560664-13-000130-index-headers.html Edgar Link pending
0001560664-13-000130-index.html Edgar Link pending
0001560664-13-000130.txt Edgar Link pending
0001560664-13-000130-xbrl.zip Edgar Link pending
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gtxo-20130930.xsd Edgar Link pending
qtxo10q_093013.htm Edgar Link pending
qtxoex311_093013.htm Edgar Link pending
qtxoex312_093013.htm Edgar Link pending
qtxoex321_093013.htm Edgar Link pending
qtxoex322_093013.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
gtxo-20130930_lab.xml Edgar Link unprocessable
gtxo-20130930_cal.xml Edgar Link unprocessable
gtxo-20130930_pre.xml Edgar Link unprocessable
gtxo-20130930_def.xml Edgar Link unprocessable
gtxo-20130930.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable